Drugs / cCTL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07434284 | Feb 2026 → Dec 2027 expected | female reproductive organ cancer | Obstetrics & Gynecology Hospital of Fudan University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cCTL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07434284 ↗ |
| Modality | Cell therapy | “Tumor-Specific Cytotoxic T Lymphocyte Injection (cCTL)” NCT07434284 ↗ |
| Route | Intravenous | “multiple intravenous infusions of cCTL” NCT07434284 ↗ |